Survey of macrolide-resistant Mycoplasma pneumoniaein children with community-acquired pneumonia in Switzerland

Patrick M. Meyer Sauteur; Barbara Bleisch; Antje Voit; Florian P. Maurer; Christa Relly; Christoph Berger; David Nadal; Guido V. Bloemberg

doi:10.4414/smw.2014.14041

Peer reviewed clinical letter

Vol. 144 No. 3940 (2014)

Survey of macrolide-resistant Mycoplasma pneumoniaein children with community-acquired pneumonia in Switzerland

Patrick M. Meyer Sauteur
Barbara Bleisch
Antje Voit
Florian P. Maurer
Christa Relly
Christoph Berger
David Nadal
Guido V. Bloemberg

DOI: https://doi.org/10.4414/smw.2014.14041
Cite this as:: Swiss Med Wkly. 2014;144:w14041
Published: 21.09.2014

References

Meyer Sauteur PM, van Rossum AM, Vink C. Mycoplasma pneumoniae in children: carriage, pathogenesis, and antibiotic resistance. Curr Opin Infect Dis. 2014;27(3):220–7.
Bebear C, Pereyre S, Peuchant O. Mycoplasma pneumoniae: susceptibility and resistance to antibiotics. Future Microbiol. 2011;6(4):423–31.
Zhao F, Liu G, Wu J, Cao B, Tao X, He L, et al. Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012. Antimicrob Agents Chemother. 2013;57(3):1521–3.
Chironna M, Sallustio A, Esposito S, Perulli M, Chinellato I, Di Bari C, et al. Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children. J Antimicrob Chemother. 2011;66(4):734–7.
Tschan A, Weisser M, Frank B, Dumke R, Tamm M, Imhof E, et al. Severe pneumonia due to macrolide-resistant Mycoplasma pneumoniae in Switzerland. Schweiz Med Forum. 2012;12(49):961–3.
Nadal D, Bossart W, Zucol F, Steiner F, Berger C, Lips U, et al. Community-acquired pneumonia in children due to Mycoplasma pneumoniae: diagnostic performance of a seminested 16S rDNA-PCR. Diagn Microbiol Infect Dis. 2001;39(1):15–9.
Hardegger D, Nadal D, Bossart W, Altwegg M, Dutly F. Rapid detection of Mycoplasma pneumoniae in clinical samples by real-time PCR. J Microbiol Methods. 2000;41(1):45–51.
Matsuoka M, Narita M, Okazaki N, Ohya H, Yamazaki T, Ouchi K, et al. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother. 2004;48(12):4624–30.
Okada T, Morozumi M, Tajima T, Hasegawa M, Sakata H, Ohnari S, et al. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Clin Infect Dis. 2012;55(12):1642–9.
Dumke R, von Baum H, Luck PC, Jacobs E. Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin Microbiol Infect. 2010;16(6):613–6.
Peuchant O, Menard A, Renaudin H, Morozumi M, Ubukata K, Bebear CM, et al. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J Antimicrob Chemother. 2009;64(1):52–8.
Spuesens EB, Fraaij PL, Visser EG, Hoogenboezem T, Hop WC, van Adrichem LN, et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med. 2013;10(5):e1001444.
Achermann R, Suter K, Kronenberg A, Gyger P, Muhlemann K, Zimmerli W, et al. Antibiotic use in adult outpatients in Switzerland in relation to regions, seasonality and point of care tests. Clin Microbiol Infect. 2011;17(6):855–61.
Harris M, Clark J, Coote N, Fletcher P, Harnden A, McKean M, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 2011;66Suppl 2(ii):1–23.

How to Cite

1.

Meyer Sauteur PM, Bleisch B, Voit A, Maurer FP, Relly C, Berger C, Nadal D, Bloemberg GV. Survey of macrolide-resistant Mycoplasma pneumoniaein children with community-acquired pneumonia in Switzerland. Swiss Med Wkly [Internet]. 2014 Sep. 21 [cited 2024 Nov. 26];144(3940):w14041. Available from: https://smw.ch/index.php/smw/article/view/1919

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Most read articles by the same author(s)

Christina T. Rüsch, Miriam Sturz, Elea Galiart, Patric M. Meyer Sauteur, Maarja Soomann, Johannes Trück, Georg M. Stettner, Impact of respiratory tract infections on spinal muscular atrophy with focus on respiratory syncytial virus infections: a single-centre cohort study , Swiss Medical Weekly: Vol. 154 No. 10 (2024)
Petra Zimmermann, Anita Uka, Michael Buettcher, Yves Fougère, Margherita Plebani, Christa Relly, Hanna Schmid, Nicole Ritz, Neonates with SARS-CoV-2 infection: spectrum of disease from a prospective nationwide observational cohort study , Swiss Medical Weekly: Vol. 152 No. 2122 (2022)
Gioia Scherler, Maren Tomaske, Vincenzo Cannizzaro, Anna Steppacher, Franziska Zucol, Martin Theiler, Laurence Toutous Trellu, Anton Labutin, Philipp P. Bosshard, Christoph Berger, Patrick M. Meyer Sauteur, Congenital syphilis in Switzerland: a retrospective cohort study, 2010 to 2019 , Swiss Medical Weekly: Vol. 153 No. 11 (2023)
Barbara Bleisch, Macé M. Schuurmans, Richard Klaghofer, Christian Benden, Annina Seiler, Josef Jenewein, Health-related quality of life and stress-related post-transplant trajectories of lung transplant recipients: a three-year follow-up of the Swiss Transplant Cohort Study , Swiss Medical Weekly: Vol. 149 No. 0708 (2019)
Agne Ulyte, Thomas Radtke, Irene A. Abela, Sarah R. Haile, Priska Ammann, Christoph Berger, Alexandra Trkola, Jan Fehr, Milo A. Puhan, Susi Kriemler, Evolution of SARS-CoV-2 seroprevalence and clusters in school children from June 2020 to April 2021: prospective cohort study Ciao Corona , Swiss Medical Weekly: Vol. 151 No. 4546 (2021)
Verena Gotta, Julia Anna Bielicki, Paolo Paioni, Chantal Csajka, Dominic Stefan Bräm, Christoph Berger, Elisabeth Giger, Michael Buettcher, Klara M. Posfay-Barbe, John van den Anker, Marc Pfister, Pharmacometric in silico studies used to facilitate a national dose standardisation process in neonatology – application to amikacin , Swiss Medical Weekly: Vol. 154 No. 4 (2024)
Patrick M. Meyer Sauteur, Alexander Moeller, Christa Relly, Christoph Berger, Barbara Plecko, David Nadal, Swiss Pediatric Surveillance Unit (SPSU), Swiss national prospective surveillance of paediatric Mycoplasma pneumoniae-associated encephalitis , Swiss Medical Weekly: Vol. 146 No. 0102 (2016)
Alessia Callegari, Karin Klingel, Janet Kelly-Geyer, Christoph Berger, Julia Geiger, Walter Knirsch, Difficulties in diagnosis of SARS-CoV-2 myocarditis in an adolescent , Swiss Medical Weekly: Vol. 152 No. 2930 (2022)
Eva Bergstraesser, David Nadal, Hilal Özgü, Peter Kleist, Deficiencies in paediatric research applications delaying ethics committee approval , Swiss Medical Weekly: Vol. 150 No. 2526 (2020)
Martin Stocker, Christoph Berger, Jane McDougall, Eric Giannoni, Recommendations for term and late preterm infants at risk for perinatal bacterial infection , Swiss Medical Weekly: Vol. 143 No. 3738 (2013)

<< < 1 2 3 > >>

[1] Meyer Sauteur PM, van Rossum AM, Vink C. Mycoplasma pneumoniae in children: carriage, pathogenesis, and antibiotic resistance. Curr Opin Infect Dis. 2014;27(3):220–7.

[2] Bebear C, Pereyre S, Peuchant O. Mycoplasma pneumoniae: susceptibility and resistance to antibiotics. Future Microbiol. 2011;6(4):423–31.

[3] Zhao F, Liu G, Wu J, Cao B, Tao X, He L, et al. Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012. Antimicrob Agents Chemother. 2013;57(3):1521–3.

[4] Chironna M, Sallustio A, Esposito S, Perulli M, Chinellato I, Di Bari C, et al. Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children. J Antimicrob Chemother. 2011;66(4):734–7.

[5] Tschan A, Weisser M, Frank B, Dumke R, Tamm M, Imhof E, et al. Severe pneumonia due to macrolide-resistant Mycoplasma pneumoniae in Switzerland. Schweiz Med Forum. 2012;12(49):961–3.

[6] Nadal D, Bossart W, Zucol F, Steiner F, Berger C, Lips U, et al. Community-acquired pneumonia in children due to Mycoplasma pneumoniae: diagnostic performance of a seminested 16S rDNA-PCR. Diagn Microbiol Infect Dis. 2001;39(1):15–9.

[7] Hardegger D, Nadal D, Bossart W, Altwegg M, Dutly F. Rapid detection of Mycoplasma pneumoniae in clinical samples by real-time PCR. J Microbiol Methods. 2000;41(1):45–51.

[8] Matsuoka M, Narita M, Okazaki N, Ohya H, Yamazaki T, Ouchi K, et al. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother. 2004;48(12):4624–30.

[9] Okada T, Morozumi M, Tajima T, Hasegawa M, Sakata H, Ohnari S, et al. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Clin Infect Dis. 2012;55(12):1642–9.

[10] Dumke R, von Baum H, Luck PC, Jacobs E. Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin Microbiol Infect. 2010;16(6):613–6.

[11] Peuchant O, Menard A, Renaudin H, Morozumi M, Ubukata K, Bebear CM, et al. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J Antimicrob Chemother. 2009;64(1):52–8.

[12] Spuesens EB, Fraaij PL, Visser EG, Hoogenboezem T, Hop WC, van Adrichem LN, et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med. 2013;10(5):e1001444.

[13] Achermann R, Suter K, Kronenberg A, Gyger P, Muhlemann K, Zimmerli W, et al. Antibiotic use in adult outpatients in Switzerland in relation to regions, seasonality and point of care tests. Clin Microbiol Infect. 2011;17(6):855–61.

[14] Harris M, Clark J, Coote N, Fletcher P, Harnden A, McKean M, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 2011;66Suppl 2(ii):1–23.